Catalyst Biosciences Inc
NASDAQ:CBIO
Income Statement
Earnings Waterfall
Catalyst Biosciences Inc
Revenue
|
794k
USD
|
Cost of Revenue
|
-798k
USD
|
Gross Profit
|
-4k
USD
|
Operating Expenses
|
-29.4m
USD
|
Operating Income
|
-29.4m
USD
|
Other Expenses
|
21.2m
USD
|
Net Income
|
-8.2m
USD
|
Income Statement
Catalyst Biosciences Inc
Dec-2020 | Dec-2021 | Dec-2022 | ||
---|---|---|---|---|
Revenue | ||||
Revenue |
21
N/A
|
7
-65%
|
1
-89%
|
|
Gross Profit | ||||
Cost of Revenue |
(9)
|
(7)
|
(1)
|
|
Gross Profit |
12
N/A
|
(0)
N/A
|
(0)
+90%
|
|
Operating Income | ||||
Operating Expenses |
(68)
|
(88)
|
(29)
|
|
Selling, General & Administrative |
(16)
|
(19)
|
(17)
|
|
Research & Development |
(52)
|
(69)
|
(12)
|
|
Operating Income |
(57)
N/A
|
(88)
-55%
|
(29)
+67%
|
|
Pre-Tax Income | ||||
Interest Income Expense |
1
|
0
|
1
|
|
Non-Reccuring Items |
(1)
|
0
|
21
|
|
Total Other Income |
1
|
(0)
|
0
|
|
Pre-Tax Income |
(56)
N/A
|
(88)
-56%
|
(8)
+91%
|
|
Net Income | ||||
Tax Provision |
0
|
0
|
(0)
|
|
Income from Continuing Operations |
(56)
|
(88)
|
(8)
|
|
Net Income (Common) |
(56)
N/A
|
(88)
-56%
|
(8)
+91%
|
|
EPS (Diluted) |
-43.98
N/A
|
-43.04
+2%
|
-3.92
+91%
|